FMP

FMP

Enter

RFL - Rafael Holdings, Inc...

Valuation of Rafael Holdings, Inc.(RFL), Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and comm

photo-url-https://financialmodelingprep.com/image-stock/RFL.png

Rafael Holdings, Inc.

RFL

NYSE

Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company's lead drug candidate is CPI-613 (devimistat), which is being evaluated in various clinical studies, including two Phase III registrational clinical trials for the treatment of metastatic pancreatic cancer and r/r acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.

1.78 USD

-0.02 (-1.12%)

Valuation Date:

Apr 17, 2024 3:00 PM

Share Price on Valuation Date

$1.78

Stock Beta

1.268

Shares Outstanding

23797300

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep